CRP and Hypertension: Male sex, body mass index ≥25 and <30 kg/m2, body mass index ≥30 kg/m2, age ≥54 years, smoking, alcohol consumption, moderate-to-severe OSAS, RLS alone or combined with PLMs, short sleep duration alone, comorbid insomnia disorder, type 2 diabetes, untreated hypertension, controlled hypertension, uncontrolled hypertension, dyslipidaemia without statin therapy, dyslipidaemia with statin therapy, cardiovascular comorbidities, aspirin therapy, and CRP levels ≥1 mg/L were more frequent in apnoeic individuals with moderate-to-high 10-year CVD risk than in those with low 10-year CVD risk (Table 3).